- Research article
- Open Access
Use of nfsB, encoding nitroreductase, as a reporter gene to determine the mutational spectrum of spontaneous mutations in Neisseria gonorrhoeae
© Stein et al; licensee BioMed Central Ltd. 2009
- Received: 23 June 2009
- Accepted: 23 November 2009
- Published: 23 November 2009
Organisms that are sensitive to nitrofurantoin express a nitroreductase. Since bacterial resistance to this compound results primarily from mutations in the gene encoding nitroreductase, the resulting loss of function of nitroreductase results in a selectable phenotype; resistance to nitrofurantoin. We exploited this direct selection for mutation to study the frequency at which spontaneous mutations arise (transitions and transversions, insertions and deletions).
A nitroreductase- encoding gene was identified in the N. gonorrhoeae FA1090 genome by using a bioinformatic search with the deduced amino acid sequence derived from the Escherichia coli nitroreductase gene, nfsB. Cell extracts from N. gonorrhoeae were shown to possess nitroreductase activity, and activity was shown to be the result of NfsB. Spontaneous nitrofurantoin-resistant mutants arose at a frequency of ~3 × 10-6 - 8 × 10-8 among the various strains tested. The nfsB sequence was amplified from various nitrofurantoin-resistant mutants, and the nature of the mutations determined. Transition, transversion, insertion and deletion mutations were all readily detectable with this reporter gene.
We found that nfsB is a useful reporter gene for measuring spontaneous mutation frequencies. Furthermore, we found that mutations were more likely to arise in homopolymeric runs rather than as base substitutions.
- Minimum Inhibitory Concentration
- Neisseria Gonorrhoeae
- Polymerase Chain Reaction Amplicon
Neisseria gonorrhoeae (GC) is an obligate human pathogen. In order to manifest the diversity of diseases that it is able to cause, GC must produce a variety of cell surface antigens such that the appropriate antigen(s) is (are) expressed in the appropriate environment at the appropriate time. Since each of the anatomical sites that GC can infect has unique physiological properties, its success in establishing itself in a new niche requires that it rapidly adapt to its new environment. To do this, it has evolved a variety of genetic mechanisms that result in high frequency antigenic variation of its surface components. These include: intramolecular recombination for pili antigenic variation ; changes in the number of pentameric DNA repeat sequences for Opa expression ; and changes in the length of a polyguanine tract for a variety of genes, including LOS variation [3, 4], pilin glycosylation , pilC expression  and iron utilization [7, 8]. Bioinformatic analysis of the GC genome has identified a variety of additional genes that may be subject to phase variation that is mediated by some form of transient DNA mispairing . Since DNA mispairings, including insertions and deletions, will arise as an intermediate in the phase variation process, and the frequency of phase variation is so high, it suggests that this pathogen should be defective in mismatch repair. However, studies in the meningococcus indicate that this organism contains a functional mismatch repair system , and homologs of all of the identified genes are present in the FA1090 genome .
In addition to the presence of a mismatch repair system, GC possesses homologs to genes that encode the proteins for recombinational repair , very short patch repair (DCS, unpublished observations), excision repair  and oxidative damage repair . This indicates that GC is capable of dealing with most errors that might arise during DNA metabolism. Previous studies on GC DNA repair indicate that GC lacks error prone and photoreactivation repair systems [15, 16]. Homologs to genes associated with error-prone repair and photoreactivation are not present. For complete review of DNA repair capacities, see review by Kline et. al.  or Ambur et. al. .
Nitroreductases have been identified in a wide variety of microorganisms [18–22]. They were originally studied because they are responsible for the reductive activation of certain nitro-group containing antimicrobial agents (e.g., nitrofurantoin), generating highly reactive electrophilic intermediates . While the physiological role of nitroreductases in bacteria is unknown, mutants lacking nitroreductases are more resistant to nitroaromatic compounds . Since the loss of gene function is associated with an increase in resistance to the antimicrobial agent, we thought that these genes might provide an ideal starting point for studying spontaneous mutation, as mutations in these genes would not be biased by the constraints of having to retain enzymatic function. We used database searches to identify a potential nitroreductase in GC, cloned and expressed the gene, verified its biochemical properties, and analyzed the DNA sequence of the gene in spontaneous nitrofurnatoin-resistant mutants.
Bacterial strains and growth media
Bacterial strains used in these studies
N. gonorrhoeae FA1090
P. Frederick Sparling
N. gonorrhoeae FA19
N. gonorrhoeae F62
P. Frederick Sparling
N. gonorrhoeae MS11
N. gonorrhoeae PID2
N. gonorrhoeae FA1090(M1)
Spontaneous nitrofurantoin resistant mutant
N. gonorrhoeae FA1090 -Nfsb(mod)
Strain with a modified poly adenine tract in the beginning of the gene
N. gonorrhoeae FA1090 NfsB-BsmI-Σ
Strain lacking NfsB
Plasmids used in these studies
General cloning vector
Plasmid containing the Σ interposon
The nfsB region from FA1090 was amplified by PCR using primers NP1 and NP2. The amplicon was purified, digested with BamHI and cloned into the BamHI site in pK18.
The DNA between the adjacent BsmI sites were removed by digesting pEC2 with BsmI, ligating the DNA and transforming it into E. coli.
Two BsmI sites were inserted into pNFSB by PCR amplification using primers NfsBBsmI-3F and -2R, treating the amplicon with S1 nuclease and polynucleotide kinase, ligating the DNA and transforming it into E. coli.
A BsrGI site was introduced downstream of the NfsB coding sequence by PCR amplification of pEC1 using primers dwnstrm-F and dwnstrm-R. The amplicon was digested with BsrGI, ligated with a DNA fragment encoding the Σ interposon (amplified from pHP45Σ using Primer OmegaABC and digested with BsrGI) and transformed into E. coli.
Isolation of DNA
Chromosomal DNA for PCR reactions was prepared from bacterial cultures by resuspending a small amount of cells in 5:l 1 M NaOH. The solution was neutralized by adding 5:l of 0.5 M Tris-HCl (pH 7.5). The suspension was further diluted in 90:l of purified water, and 1:l of this solution was used as a template for PCR. Plasmid DNA isolations were carried out according to the alkaline lysis procedure .
Primers used in these studies
DNA sequence analysis
DNA sequencing was performed by Macrogen, Inc. (Seoul, Kr.) or the DNA sequencing facility at the Center for Biosystems research at the University of Maryland. All nfsB sequences were obtained using Primers S1 and S2.
Molecular biology procedures
All procedures were performed using methods described in Sambrook et al. . When biological reagents were used, they were used under the conditions described by their manufacturer. Restriction enzymes, T4 DNA ligase, polynucleotide kinase and appropriate buffers were obtained from New England Biolabs (Beverly, MA). S1 nuclease was obtained from Promega (Madison, WI). DNA samples were analyzed on agarose gels (0.8-1.0%) in TBE buffer .
Transformation-competent E. coli cells (strain DH5α-mcr) were prepared using the procedure of Inuoe , and stored at -80°C. To prepare cells for transformation, cells were thawed on ice, DNA added and the mixture incubated on ice for 10 min. The bacteria were heat-shocked at 37°C for 2 min., the total volume in the tube was increased to 1 ml by adding LB broth and the transformation mixture incubated at 37°C for 30 min. to 1 hr. to allow the bacteria to recover and begin expressing antibiotic-resistance proteins. Transformed bacteria were plated onto LB agar plates containing appropriate antibiotics and, if necessary, X-gal.
For transformation of N. gonorrhoeae, piliated bacteria were resuspended to light turbidity in 1 ml GCK+ 10 mM MgCl2 + Kellogg's supplement + 0.42% NaHCO3. DNA was added to the culture, and the bacteria were incubated at 37°C with shaking for 2-6 hours. Bacteria were plated onto GCK agar plates containing the appropriate antibiotic, and the plates incubated for 36-48 hrs. When transformations were performed under nonselective conditions, a spot transformation procedure was used . For transformation, two piliated colonies were resuspended in 100:l GCP + 200 mM MgCl2 + 0.42% NaHCO3 + Kellogg's supplement. The cell suspension was diluted 1:10, and additional two-fold serial dilutions were then carried out 9 times. An aliquot (5:l) of each suspension was spotted onto a GCK agar plate. To each spot, 5:l of DNA were added. After incubation overnight at 37°C with 4% CO2, individual colonies were isolated and streaked for isolation on GCK agar plates. The next day, individual colonies were inoculated onto GCK and spectinomycin-containing GCK agar plates. This procedure was repeated until spectinomycin-sensitive colonies were obtained. The correct replacement of the desired DNA fragment by the transformation process was verified by PCR amplification of the desired region, and restriction digestion analysis of the PCR amplicon, or direct DNA sequencing of the PCR amplicon.
Sequence modification of nfsB
The nfsB gene from strain FA1090 was amplified by PCR using primers NP1 and NP2. The amplicon was purified, digested with BamHI and cloned into the BamHI site in pK18, resulting in plasmid pNFSB. To alter the poly adenine sequence at the 5' end of the gene from AAAAA to AAGAA, PCR primers NfsB-BsmI-F and NfsB-BsmI-R were designed. The resulting amplicon was digested with BsmI, ligated, and introduced into E. coli by transformation, giving pEC1. Plasmid pEC1 was amplified via PCR using the primers dwnstrm-F and dwnstrm-R, allowing for the insertion of a BsrGI site. A spectinomycin resistance cassette was amplified from pMP45Σ using primer Omega-ABC, and ligated into the BsrG1 site, resulting in pEC3. This plasmid was used to transform strain FA1090 to spectinomycin resistance, resulting in strain NfsB-BsmI-Ω. The spectinomycin resistance cassette was removed using the spot transformation procedure  with pEC1, producing a strain that had an intact modified nfsB gene(FA1090-NfsB(mod)). The correct construction was verified by DNA sequence analysis of a PCR amplicon. The DNA sequences for nfsB from the various strains have been submitted to GenBank with the following accession numbers: F62, GU112780; MS11, GU112781; FA19, GU112782; and PID2, GU112783. Point mutations in nfsB that resulted in nitrofurantoin resistance are identified in GenBank as accession numbers: GU112770; GU112771; GU112772; GU112773; GU112774; GU112775; GU112776; GU112777; GU112778; and GU112779.
The minimum inhibitory concentration (MIC) of nitrofurantoin for several gonococcal strains was determined by a plate dilution method. Approximately 108 gonococci were spotted onto media containing various amounts of nitrofurantoin (1 μg/ml, 2 μg/ml, 3 μg/ml, 4 μg/ml, 6 μg/ml, 8 μg/ml, 16 μg/ml and 32 μg/ml). The inoculated plates were incubated overnight, and the MIC was defined as the amount of nitrofurantoin needed in the plate to completely inhibit the growth of the organisms in 24 hours.
Spontaneous mutation frequency determination
Cultures of GC were grown in GCP broth + 0.42% NaHCO3 and Kellogg's supplement to exponential growth phase, and aliquots (~1 × 108 cfu) plated onto GCK plates containing 3:g/ml nitrofurantoin. Viable counts were determined by plating cells onto GCK agar plates. Mutation frequencies were defined as the number of colonies obtained on nitrofurantoin-containing media divided by the number of colonies obtained on GCK media.
Nitroreductase activity was measured by a modification of the method of Whiteway et al. . Cultures (100 ml) of GC were grown in GCP broth + 0.42% NaHCO3 and Kellogg's supplement at 37°C with shaking to a turbidity of 100 klett units. Cells were collected by centrifugation (~4,000 rpm for 10 min in a Sorvall GSA rotor), washed with PBS, and resuspended in 5 ml 100 mM Tris-HCl, pH 7.5. Cells were lysed by sonication using a Branson sonicator with the microprobe, set on full power, using 5 10 sec pulses (Suspensions were incubated on ice for 1 min between pulses). The sonicates were clarified by centrifugation (~10,000 rpm for 30 min in a Sorvall SS-34 rotor) and the supernatants collected. Protein concentrations of each sample were measured with the BioRad protein assay (Hercules, CA) using BSA as a standard, and samples were normalized to the same protein concentration in 100 mM Tris-HCl, pH 7.5. Samples containing 800:l lysate and 0.1 mM nitrofurazone were placed in a quartz cuvette, and the reaction initiated by adding 100:l NADPH (2 mM stock). A control reaction was performed using water instead of nitrofurazone. Reactions were incubated at room temperature and absorbance was measured every 30 sec at 400 nm.
A homolog of E. coli nfsB in the gonococcus was identified by submitting the entire E. coli nfsB protein sequence to http://blast.ncbi.nlm.nih.gov/Blast.cgi using the tblastn program. The database option was set to "nucleotide collection," and limited to Neisseria gonorrhoeae. The database option was set to "bacteria," and the number of best-scoring sequences to show was set to 250. The top scoring hits from unique genera were aligned using ClustalW http://www.ebi.ac.uk/Tools/clustalw/.
MIC/Spontaneous Mutation Frequency Studies
Identification of potential nitroreductase genes
E. coli possesses two nitroreductases that can reduce these nitro-aromatic compounds; nfsA and nfsB, plus a nitroreductase activity encoded by a gene that has yet to be identified [18, 24]. Therefore, it is possible that GC may possess additional genes that confer nitroreductase activity. In E. coli, resistance to these nitro-aromatic antimicrobial agents occurs in a step-wise manner. A mutation that knocks out the function of NfsA raises the MIC about three fold. A second mutation that knocks out the function of NfsB increases resistance to about 10 times the MIC of wild-type strains [18, 24]. All attempts to isolate second-step mutants in N. gonorrhoeae were unsuccessful, indicating that this species only contains a single functional nitroreductase, or that the additional nitroreductases were insensitive to nitrofurantoin.
DNA sequence analysis of nfsBfrom various gonococcal strains
The nfsB DNA sequence for N. gonorrhoeae strains F62, FA19, MS11, and PID2 was determined by sequencing PCR products amplified from their respective chromosomes. Sequence data were derived from multiple independent amplicons. The data indicated that the DNA sequence was highly conserved as all sequences obtained were identical to the nfsB DNA sequence of FA1090, with the exception of strain PID2. This strain possessed a single nucleotide polymorphism (using the adenine of the start codon as base one, at base 575 from the start codon, this base is a guanine in FA1090 and a cytosine in PID2) that would result in an amino acid substitution in NfsB at residue 192 (a glycine in FA1090 and an alanine in PID2). Since these proteins were essentially identical, it suggests that the variability in spontaneous mutation frequencies observed in these strains could reflect different DNA repair capacities for the various strains.
Nitroreductase activity in N. gonorrhoeae
Genetic basis of nitrofurantoin resistance
In order to verify that the nitrofurantoin resistance observed in the mutant was due to alterations in nfsB, the DNA sequence of this region was determined from spontaneous nitrofurantoin resistant mutants by amplifying the nfsB region from this strain. The data indicate that FA1090(M1) possessed a small insertion of 7 nucleotides about midway through the coding sequence, producing a frame shift mutation in nfsB. This genetic data supported the hypothesis that the nitrofurantoin resistant phenotype is due to the loss of nitroreductase activity. Conclusive evidence that this gene was responsible for nitrofurantoin resistance was obtained by deleting the coding sequence for this gene from FA1090 and then demonstrating that FA1090NfsB-BsmIS lacked nitroreductase activity (data not shown).
Identification of the genetic basis of spontaneous nitrofurantoin resistant mutants
We isolated numerous independent spontaneous nitrofurantoin resistant mutants and determined the DNA sequence of the nfsB gene in these strains. Most of these mutants (90%) possessed the insertion of an adenine in a run of 5 adenines near the beginning of the gene, suggesting a bias for base insertion during DNA replication at this position. This gene contains three other polynucleotide runs of five nucleotides distal to the start codon; 2 poly adenines and one polythymine. Interestingly, even though we were able to isolate base insertions at each of these three clusters, none of the clusters showed the elevated propensity for generating spontaneous mutations.
Analysis of mutations resulting in nitrofurantoin resistance
Insertions (single site)
Deletions (single site)
Mutations in promoter region
Use of nonsense mutations to characterize transition and transversion rates
Any point mutation that is capable of generating a stop codon could generate a cell that is resistant to the killing action of nitrofurantoin. Visual analysis of the coding sequence for nfsB identified 23 possible bases where a single base change would result in the production of a stop codon. We identified 33 mutations that resulted from this type of base change. The distribution of the mutations obtained suggested that no hot spot for mutation existed in any of these sequences (see Table 4). We obtained a total of 27 transition mutations and 26 transversion mutations, suggesting that no preference exists for generating these types of mutations. Interestingly, the number of deletion and insertion mutations occurred at approximately the same frequency as the number of transition and transversions.
Analysis of mutations
Phase variation is a reversible, high-frequency phenotypic switching that is mediated by changes in the DNA sequence that effects the expression of the target gene. The ability of individual genes to phase vary contributes to population diversity and is important in niche adaptation. Understanding which genes are capable of undergoing phase variation is the first step defining which genes are important in disease pathogenesis. Being able to determine the rate at which these processes occur and the nature of any factors that influence them is integral to understanding the impact of these processes on the evolution and dynamics of the population as a whole and on the host-bacterium interaction. Studies on phase variation in the gonococcus have been hampered by our lack of knowledge of background mutation frequencies.
We reasoned that analysis of genes, whose loss of function would provide for a positive selection, would allow for an unbiased comparative analysis of spontaneous mutations, and the study of spontaneous mutation in these genes would provide baseline information for future studies on factors that might effect antigenic variation. We further reasoned that with this knowledge, we could distinguish between changes in gene expression that were the result of slip strand mispairing during DNA replication from changes due to other forms of mistakes that occur during DNA replication.
We determined that N. gonorrhoeae encodes a nitroreductase gene (nfsB). The inability to isolate second-step nitrofurantoin resistant mutants suggested that the gonococcus only contained a single nitroreductase. We obtained biochemical data to support this conclusion, where mutants that were resistant to nitrofurantoin lost the ability to reduce nitrofurantoin. Since cell lysates that did not contain the co-factor NADPH had no nitroreductase activity, it indicated an absolute requirement for this co-factor. However, we did not determine if other molecules such as NADH could substitute for the NADPH requirement, or if the organism might have other nitroreductases that utilized a cofactor other than NADPH.
We determined the nature of spontaneous mutation by analyzing where mutations occurred in nfsB. While we were able to identify mutations that would result in amino acid substitutions in the region involved in FMN binding , the majority of the mutations were outside of this region, with most of them clustering in the amino terminus of the protein. This was somewhat surprising, given that this region of the protein is not well conserved in known nitroreductases.
The results of the spontaneous mutation frequency plating experiments and the subsequent genetic analysis showed that nitrofurantoin resistance is a potential target for analyzing mutation in the gonococcus. The fact that almost all mutations originally examined resulted in an extension of a polyadenine run of 5 adenines was surprising, as it is thought that this sequence is too short to participate in strand slippage. Furthermore, the absence of slippage at two other polyadenine runs of 5 in other locations indicates that sequence context is important in strand slippage.
The use of nfsB as a reporter system allowed us to assess the nature of spontaneous mutation in an unbiased fashion. If one removes the high frequency of errors that occurred in the polynucleotide run of adenines, the propensity of errors directed towards transitions and transversions occurred at a similar frequency to insertion or deletion mutations. However, the high rate of insertions and deletions is in contrast to what was observed by Schaaper and Dunn , who in their studies of spontaneous mutation in the lacI gene of Escherichia coli saw that single base insertions and deletions only made up 4.2% of their observed mutations. While we observed that single base insertions and deletions accounted for ~40% of our observed mutations in a background where a run of five adenines was removed, if the bias observed at this sequence was included, insertions would have made up about 75% of all observed mutations. The implication of this finding would suggest that homopolymeric runs should have a tendency to increase, and that they should dominate the types of mutations seen in the gonococcus. This is precisely what is observed. The mechanism by which gonococcal DNA polymerase allows this to occur, and the inability of the gonococcus to efficiently correct insertions indicates that gonococcal DNA repair is somewhat different from that seen in E. coli.
Most of our understanding of DNA repair in the Neisseria has come from studies focused on understanding the contribution of various DNA repair proteins in preventing mutations in rpoB in the gonococcus or meningococcus. These studies have analyzed numerous strains for the rate of spontaneous resistance to rifampicin, and find that in general, this rate is between ~1 × 10-8 - 1 × 10-9 [33–36]. Our data indicate that mutants resistant to nitrofurantoin arose at a much higher frequency (~3 × 10-6 - 8 × 10-8). We believe that the higher mutation frequencies that we observed relate to the nature of the selection procedure employed. Mutation screens designed to detect rpoB mutants are constrained in that they must result in the production of a functional protein. Our screening procedure allowed us to detect any mutation that results in the loss of function of the target, and hence is able to identify insertions and deletions, as well as point mutations. We believe that the elevated mutation frequency that we observed for nfsB, relative to that observed by others for rpoB was due to the presence of the polyadenine sequence in nfsB and our ability to detect frame shift mutations.
Race and coworkers  have solved the crystal structure of NfsB isolated from E. coli. Interestingly, none of the mutations that we identified were contained in any of the key residues that they demonstrated to be interacting with nitrofurantoin. However, a significant number of the amino acid substitutions that we identified would be expected to have dramatic structural implications.
In summary, we found that nfsB is a useful reporter for measuring spontaneous mutation frequencies. Its ability to detect elevated mutation frequencies in very short polynucleotide runs indicates that any gene that contains a short polynucleotide run has the potential to phase vary.
The work described in this paper was supported in part by a grant from the National Institutes of Health to DCS, Grant number AI 24452. Support for this research was also provided by a grant from the Howard Hughes Medical Institute through the Undergraduate Biological Sciences Education Program to Esteban Carrizosa.
- Meyer TF, Mlawer N, So M: Pilus expression in Neisseria gonorrhoeae involves chromosomal rearrangements. Cell. 1982, 30: 45-52. 10.1016/0092-8674(82)90010-1.PubMedView ArticleGoogle Scholar
- Stern A, Brown M, Nickel P, Meyer TF: Opacity genes of Neisseria gonorrhoeae: control of phase and antigenic variation. Cell. 1986, 47: 61-71. 10.1016/0092-8674(86)90366-1.PubMedView ArticleGoogle Scholar
- Banerjee A, Wang R, Uljohn S, Rice PA, Gotschlich EC, Stein DC: Identification of the gene (lgtG) encoding the lipooligosaccharide β chain synthesizing glucosyl transferase from Neisseria gonorrhoeae. Proc Natl Acad Sci USA. 1998, 95: 10872-10877. 10.1073/pnas.95.18.10872.PubMed CentralPubMedView ArticleGoogle Scholar
- Danaher RJ, Levin JC, Arking D, Burch CL, Sandlin R, Stein DC: Genetic basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation. J Bacteriol. 1995, 177 (24): 7275-7279.PubMed CentralPubMedGoogle Scholar
- Banerjee A, Wang R, Supernavage SL, Ghosh SK, Parker J, Ganesh NF, Wang PG, Gulati S, Rice PA: Implications of phase variation of a gene (pgtA) encoding a pilin galactosyl transferase in gonococcal pathogenesis. J Exp Med. 2002, 196 (2): 147-162. 10.1084/jem.20012022.PubMed CentralPubMedView ArticleGoogle Scholar
- Jonsson AB, Nyberg G, Normark S: Phase variation of gonococcal pili by frameshift mutation in pilC, a novel gene for pilus assembly. EMBO J. 1991, 10 (2): 477-488.PubMed CentralPubMedGoogle Scholar
- Carson SD, Stone B, Beucher M, Fu J, Sparling PF: Phase variation of the gonococcal siderophore receptor FetA. Mol Microbiol. 2000, 36 (3): 585-593. 10.1046/j.1365-2958.2000.01873.x.PubMedView ArticleGoogle Scholar
- Chen CJ, Elkins C, Sparling PF: Phase variation of hemoglobin utilization in Neisseria gonorrhoeae. Infect Immun. 1998, 66 (3): 987-993.PubMed CentralPubMedGoogle Scholar
- Jordan PW, Snyder LA, Saunders NJ: Strain-specific differences in Neisseria gonorrhoeae associated with the phase variable gene repertoire. BMC Microbiol. 2005, 5 (1): 21-10.1186/1471-2180-5-21.PubMed CentralPubMedView ArticleGoogle Scholar
- Richardson AR, Stojiljkovic I: Mismatch repair and the regulation of phase variation in Neisseria meningitidis. Mol Microbiol. 2001, 40 (3): 645-655. 10.1046/j.1365-2958.2001.02408.x.PubMedView ArticleGoogle Scholar
- Kline KA, Sechman EV, Skaar EP, Seifert HS: Recombination, repair and replication in the pathogenic Neisseriae: the 3 R's of molecular genetics of two human-specific bacterial pathogens. Mol Microbiol. 2003, 50 (1): 3-13. 10.1046/j.1365-2958.2003.03679.x.PubMedView ArticleGoogle Scholar
- Skaar EP, Lazio MP, Seifert HS: Roles of the recJ and recN genes in homologous recombination and DNA repair pathways of Neisseria gonorrhoeae. J Bacteriol. 2002, 184 (4): 919-927. 10.1128/jb.184.4.919-927.2002.PubMed CentralPubMedView ArticleGoogle Scholar
- Campbell LA, Yasbin RE: A DNA excision repair system for Neisseria gonorrhoeae. Mol Gen Genet. 1984, 193 (3): 561-563. 10.1007/BF00382101.PubMedView ArticleGoogle Scholar
- Nyaga SG, Lloyd RS: Two glycosylase/abasic lyases from Neisseria mucosa that initiate DNA repair at sites of UV-induced photoproducts. J Biol Chem. 2000, 275 (31): 23569-23576. 10.1074/jbc.M000628200.PubMedView ArticleGoogle Scholar
- Campbell LA, Yasbin RE: Deoxyribonucleic acid repair capacities of Neisseria gonorrhoeae: absence of photoreactivation. J Bacteriol. 1979, 140: 1109-1111.PubMed CentralPubMedGoogle Scholar
- Campbell LA, Yasbin RE: Mutagenesis of Neisseria gonorrhoeae: Absence of error-prone repair. J Bacteriol. 1984, 160: 288-293.PubMed CentralPubMedGoogle Scholar
- Ambur OH, Davidsen T, Frye SA, Balasingham SV, Lagesen K, Rognes T, Tonjum T: Genome dynamics in major bacterial pathogens. FEMS Microbiology Reviews. 2009, 33 (3): 453-470. 10.1111/j.1574-6976.2009.00173.x.PubMed CentralPubMedView ArticleGoogle Scholar
- Bryant DW, McCalla DR, Leeksma M, Laneuville P: Type I nitroreductases of Escherichia coli. Can J Microbiol. 1981, 27 (1): 81-86.PubMedView ArticleGoogle Scholar
- Jorgensen MA, Trend MA, Hazell SL, Mendz GL: Potential involvement of several nitroreductases in metronidazole resistance in Helicobacter pylori. Arch Biochem Biophys. 2001, 392 (2): 180-191. 10.1006/abbi.2001.2427.PubMedView ArticleGoogle Scholar
- Koder RL, Haynes CA, Rodgers ME, Rodgers DW, Miller AF: Flavin thermodynamics explain the oxygen insensitivity of enteric nitroreductases. Biochemistry. 2002, 41 (48): 14197-14205. 10.1021/bi025805t.PubMedView ArticleGoogle Scholar
- Watanabe M, Nishino T, Takio K, Sofuni T, Nohmi T: Purification and characterization of wild-type and mutant "classical" nitroreductases of Salmonella typhimurium. L33R mutation greatly diminishes binding of FMN to the nitroreductase of S. typhimurium. J Biol Chem. 1998, 273 (37): 23922-23928. 10.1074/jbc.273.37.23922.PubMedView ArticleGoogle Scholar
- Zenno S, Kobori T, Tanokura M, Saigo K: Purification and characterization of NfrA1, a Bacillus subtilis nitro/flavin reductase capable of interacting with the bacterial luciferase. Biosci Biotechnol Biochem. 1998, 62 (10): 1978-1987. 10.1271/bbb.62.1978.PubMedView ArticleGoogle Scholar
- McOsker CC, Fitzpatrick PM: Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother. 1994, 33 (suppl): 23-30.PubMedView ArticleGoogle Scholar
- Whiteway J, Koziarz P, Veall J, Sandhu N, Kumar P, Hoecher B, Lambert IB: Oxygen-insensitive nitroreductases: analysis of the roles of nfs A and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli. J Bacteriol. 1998, 180 (21): 5529-5539.PubMed CentralPubMedGoogle Scholar
- White LA, Kellogg DS: Neisseria gonorrhoeae identification in direct smears by a fluorescent antibody counterstain method. Appl Microbiol. 1965, 13: 171-174.PubMed CentralPubMedGoogle Scholar
- Birnboim HC, Doly J: A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucl Acids Res. 1979, 7: 1513-1523. 10.1093/nar/7.6.1513.PubMed CentralPubMedView ArticleGoogle Scholar
- Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: a laboratory manual. 1989, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2Google Scholar
- Inoue H, Nojima H, Okayama H: High efficiency transformation of Escherichia coli with plasmids. Gene. 1990, 96 (1): 23-28. 10.1016/0378-1119(90)90336-P.PubMedView ArticleGoogle Scholar
- Gunn JS, Stein DC: Use of a non-selectable transformation technique to construct a multiple restriction modification deficient mutant of Neisseria gonorrhoeae. Mol Gen Genet. 1996, 251: 509-517.PubMedGoogle Scholar
- Zenno S, Koike H, Tanokura M, Saigo K: Gene cloning, purification, and characterization of NfsB, a minor oxygen-insensitive nitroreductase from Escherichia coli, similar in biochemical properties to FRase I, the major flavin reductase in Vibrio fischeri. J Biochem (Tokyo). 1996, 120 (4): 736-744.View ArticleGoogle Scholar
- Zenno S, Koike H, Kumar AN, Jayaraman R, Tanokura M, Saigo K: Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase. J Bacteriol. 1996, 178 (15): 4508-4514.PubMed CentralPubMedGoogle Scholar
- Schaaper RM, Dunn RL: Spontaneous mutation in the Escherichia coli lacI gene. Genetics. 1991, 129: 317-326.PubMed CentralPubMedGoogle Scholar
- Davidsen T, Tuven HK, Bjoras M, Rodland EA, Tonjum T: Genetic interactions of DNA repair pathways in the pathogen Neisseria meningitidis. Journal of Bacteriology. 2007, 189 (15): 5728-5737. 10.1128/JB.00161-07.PubMed CentralPubMedView ArticleGoogle Scholar
- Davidsen T, Amundsen EK, Rodland EA, Tonjum T: DNA repair profiles of disease-associated isolates of Neisseria meningitidis. Fems Immunology and Medical Microbiology. 2007, 49 (2): 243-251. 10.1111/j.1574-695X.2006.00195.x.PubMedView ArticleGoogle Scholar
- Davidsen T, Bjoras M, Seeberg EC, Tonjum T: Antimutator role of DNA glycosylase MutY in pathogenic Neisseria species. Journal of Bacteriology. 2005, 187 (8): 2801-2809. 10.1128/JB.187.8.2801-2809.2005.PubMed CentralPubMedView ArticleGoogle Scholar
- Colicchio R, Pagliarulo C, Lamberti F, Vigliotta G, Bruni CB, Alifano P, Salvatore P: RecB-dependent mutator phenotype in Neisseria meningitidis strains naturally defective in mismatch repair. DNA Repair. 2006, 5 (12): 1428-1438. 10.1016/j.dnarep.2006.07.001.PubMedView ArticleGoogle Scholar
- Race PR, Lovering AL, Green RM, Ossor A, White SA, Searle PF, Wrighton CJ, Hyde EI: Structural and mechanistic studies of Escherichia coli nitroreductase with the antibiotic nitrofurazone: reversed binding orientations in different redox states of the enzyme. J Biol Chem. 2005, 280: 13256-13264. 10.1074/jbc.M409652200.PubMedView ArticleGoogle Scholar
- Pridmore RD: New and versatile cloning vectors with kanamycin-resistance marker. Gene. 1987, 56: 309-312. 10.1016/0378-1119(87)90149-1.PubMedView ArticleGoogle Scholar
- Swartley JS, Ahn JH, Liu LJ, Kahler CM, Stephens DS: Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region. J Bacteriol. 1996, 178 (14): 4052-4059.PubMed CentralPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.